Summary of main findings in genome-wide association study (GWAS) and validation stages in risk* of follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), or marginal zone lymphoma (MZL), per study and combined.

*The trend test P-value for each study is shown with the corresponding odds ratios (OR) and confidence interval (CI) below.**Additional adjustment for rs6457327, rs4947332, rs1794265, rs1800629, rs2517448 did not confer other than marginal changes.†Test of heterogeneity carried out assuming heterogeneity of effect of the “other” SNP.SCALE: Scandinavian Lymphoma Etiology; SF: San Francisco; BC: British Columbia; NCI-SEER: National Cancer Institute-Surveillance, Epidemiology and End Results; NSW: New South Wales.